Daily Equity Reports 09 Jan 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 09th JANUARY 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 35980.93 INDIAN EQUITY BENCHMARK :- A recovery in the final hour of trade ensured that benchmarks maintained their positive 10802.15 streak.Among sectors, weakness was visible in energy, infra and ASIAN MARKET IT names, while the Nifty Midcap index also fell one-fifth of a CLOSE PREVIOUS percent. Pharmaceuticals gained the most, courtesy a huge NIKKEI 20204.04 rally in Sun Pharmaceuticals. GLOBAL FACE 25875.45 2037.10 ! SECTORIAL INDICES Asian Market - Asian markets finished mixed as of the most recent closing prices. The Nikkei 225 gained 0.82% and the Hang Seng rose 0.15%. The Shanghai Composite lost 0.26%. CLOSE CHANGE (%) 11031.30 0.24 ! U.S. Market – European stocks move higher as US-China trade talks continue. 0.19 0.28 ! European markets - European markets are broadly higher today with 0.19 shares in France leading the region. The CAC 40 is up 1.18% while .BANK NIFTY 27509.50 0.75 London's FTSE 100 is up 0.81% and Germany's DAX is up 0.62%. CLOSE CHANGE (%) 4.17 ICICI BANK 3.15 3.10 2.62 TOP LOSERS CLOSE CHANGE (%) -2.99 UPL 751 -1.67 -1.49 BPCL -1.38 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE TREND STRATEGY SCRIPT CLOSE (%) 4.70 BEARISH 3.98 P R1 R2 10869 RESISTANCE R1-10860 R2-10950 R3 10954 10614 10699 10750 10784 10835 3.46 ICICI BANK S1-10690 S2-10610 3.18 SBI CLOSE (%) -3.30 1246.15 -2.71 APOLLOHOSP -2.36 ZEEL -2.36 TREND BULLISH NET (CR.) 4252.17 S3 S2 S1 27390 P R1 R2 R3 26831 27171 27511 27730 DII 2492.80 RESISTANCE BANK NIFTY NSE TOTALS ADVANCE Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! Lupin gets European approval for ! Exide Industries to invest up to 30% equity stake in Cleantech at Rs20cr Exide Industries to invest up to 30% equity stake in Cleantech aggregating to Rs20.05cr for setting up captive solar power projects for various manufacturing facilities. The company made announcement after market hours.The company has agreed to invest upto 30% of total equity share capital in each of the three special purpose vehicle(s) viz., "CSE Solar Sunpark Haryana Private Limited", "CSE Solar Sunpark Maharashtra Private Limited" and "Greenyana Solar Private Limited" (hereinafter collectively called as Cleantech) aggregating upto Rs20cr for setting up captive solar power projects for various manufacturing facilities of the Company. NaMuscla Lupin, on Tuesday, announced that the European Commission (EC) has approved its novel, rare disorder drug NaMuscla. This drug is indicated in the treatment of inherited neuromuscular disorders called non-dystrophic myotonic (NDM) disorders in adults, where muscles are unable to relax and lead to voluntary contraction. ! Cadila receives USFDA approval to market Aripiprazole Cadila Healthcare, in a filing to the exchanges on Tuesday, informed that it has received approval from the US Food and Drug Administration (USFDA) to market Aripiprazole Tablets USP (US RLD- Abilify) in the strengths of 2mg, 5mg, 10mg, 15mg, 20mg, and 30mg. ! ICICI Prudential Life witnesses positive APE growth during December 2018 ICICI Prudential Life Insurance Company (IPru Life) reported 3% growth in its annual premium equivalent (APE) during the month of December 2018. The company has been able to arrest the decline in APE growth since November 2018. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : SUNPHARMA DATE : 08/01/2019 SEGMENT : CASH CHART TYPE : Candlestick : NSE : NSE EXCHANGE EXCHANGE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL :- BUY SUNPHARMA IN CASH ABOVE 450 TGT 460 SL 440 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF TREND REVERSAL IS THERE. OTHER REASON IF ANY :- OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.